ATI System Disorder Hyperkalemia PDF

Title ATI System Disorder Hyperkalemia
Course Pharmacology for Professional Nursing
Institution Rasmussen University
Pages 1
File Size 87.3 KB
File Type PDF
Total Downloads 5
Total Views 185

Summary

ATI System Disorder Template Worksheet on Hyperkalemia...


Description

ACTIVE LEARNING TEMPLATE:

System Disorder

Jaime Hanzlik ST UDENT NAME _____________________________________ Hypokalemia DISORDER/DISEASE PROCESS __________________________________________________________

Alterations in Health (Diagnosis)

Pathophysiology Related to Client Problem

REVIEW MODULE CHAPTER ___________

Health Promotion and Disease Prevention

Loss of potassium from the body or movement of potassium into the cells, resulting in a blood potassium less than 3.5 mEq/L.

ASSESSMENT

SAFETY CONSIDERATIONS

Risk Factors

Expected Findings

Overuse of diuretics, digitalis, corticosteroids; increased secretion of aldosterone; Cushing's syndrome; loss via GI tract; alkalosis; hyperinsulinism; water intoxication.

Laboratory Tests

Hypotension, thready weak pulse, orthostatic hypotension, lethargy, altered LOC, hypoactive bowel sounds, nausea, vomiting, muscle weakness, reduced deep-tendon reflexes, shallow breathing.

Diagnostic Procedures

Blood potassium level less than 3.5 mEq/L

ECG- Inverted/flat T waves, ST depression, elevated U wave, other dysrhythmia possible.

PATIENT-CENTERED CARE

Nursing Care Administer prescribed medication, monitor I&O, respirations, cardiac rhythm, monitor LOC, assess DTRs

Complications Medications Potassium replacement

Client Education Understanding of potassium-rich foods, avoiding excessive use of diuretics and laxatives to prevent a decrease in potassium.

Therapeutic Procedures

Interprofessional Care

Administer medications as prescribed, oral replacement of potassium, IV potassium supplementation

Nephrology, respiratory services, nutritional services, cardiology

ACTIVE LEARNING TEMPLATES

Monitor vital signs every 4 hours, monitor I&O, implement fall precautions due to muscle weakness.

Respiratory failure, cardiac arrest. Patients receiving digoxin monitor for increased risk of toxicity.

THERAPEUTIC PROCEDURE

A11...


Similar Free PDFs